Improved ventilation and decreased sympathetic stress in chronic heart failure patients following local endurance training with leg muscles

Journal of Cardiac Failure

Volumn 3, Issue 1, 1997, Pages 3-12

  Gordon, Allan ^a   Tyni Lenné, Raija ^a   Jansson, Eva ^a   Kaijser, Lennart ^a   Theodorsson Norheim, Elvar ^a   Sylvén, Christer ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Exercise capacity; Heart failure; Skeletal muscle; Sympathetic stress; Ventilation

Indexed keywords

ADRENALIN; ATRIAL NATRIURETIC FACTOR; LACTIC ACID; NEUROPEPTIDE Y; NORADRENALIN;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; BLOOD; CONGESTIVE HEART FAILURE; EXERCISE TOLERANCE; HEART RATE; HUMAN; KINESIOTHERAPY; LEG; MALE; METABOLISM; MIDDLE AGED; MUSCLE CONTRACTION; PATHOLOGY; PATHOPHYSIOLOGY; QUALITY OF LIFE; SKELETAL MUSCLE;

ADULT; AGED; ATRIAL NATRIURETIC FACTOR; EPINEPHRINE; EXERCISE THERAPY; EXERCISE TOLERANCE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; LACTIC ACID; LEG; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SKELETAL; NEUROPEPTIDE Y; NOREPINEPHRINE; QUALITY OF LIFE; SYMPATHETIC NERVOUS SYSTEM;

EID: 0031084822     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(97)90002-6     Document Type: Article

References (39)

1. LeJemtel TH, Maskin CS, Lucido D, Chadwick MJ. Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure. Circulation 1986;74:245-51
2. Wilson JR, Martin JL, Schwartz D, Ferraro N. Exercise intolerance in patients with chronic heart failure: Role of impaired nutritive flow to skeletal muscle. Circulation 1984;69:1079-87
3. 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation 1989; 80:1338-46
4. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with chronic heart failure. Circulation 1990;81:518-27
5. Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with severe left ventricular dysfunction. Circulation 1988;78:596-615
6. Coats AJS, Adamopoulos S, Radaelli A, McCance A, Meyer TE, Bernardi L, Solda PL, Davey P, Ormerod O, Forfar C, Conway J, Sleight P. Controlled trial of physical training in chronic heart failure. Circulation 1992;85: 2119-31
7. Minotti JR, Johnsson EC, Hudson TL, Zuroske G, Murata G, Fukushima E, Cagle TG, Chich TW, Massie BM, Icenogle MV. Skeletal muscle response to exercise training in congestive heart failure. J Clin Invest 1990;86:751-8
8. Szlachcic S, Massie BM, Kramer BL, Topic N, Turban I. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol 1985;55: 1037-42
9. Adamopoulus S, Coats AJS, Brunotte F. Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol 1993;21:1101-6
10. Gordon A, Tyni-Lenné R, Persson H, Kaijser L, Hultman E, Sylvén C. Markedly improved skeletal muscle function with local muscle training in patients with chronic heart failure. Clin Cardiol 1996;19:568-74
11. Piepoli M, Clark AL, Volterrani M, Adamopoulos S, Sleight P, Coats AJS. Contricution of muscle afferents to the hemodynamic autonomic and ventilatory responses to exercise in patients with chronic heart failure. Effects of physical training. Circulation 1996;93:940-52
12. Leimbach WH, Wallin G, Victor RG, Aylwarld PE, Sundlöf E, Mark A. Direct evidence from intraneural recordings for central sympathetic outflow in patients with heart failure. Circulation 1986;73:913-19
13. Saul JP, Arai Y, Berger RD, Lilly LS, Colucci WS, Cohen TJ. Assessment of autonomic regulation in chronic congestive heart failure. Am J Cardiol 1988;61:1292-9
14. Chidsey CA, Harrison DC, Braunwald E. Augmentation of the plasma norepinephrine response to exercise in patients with congestive heart failure. N Engl J Med 1962;267: 650-4
15. Thomas JA; Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978;41:233-43
16. Raine A, Phil D, Erne P, Biirgisser E, Müller F, Bolli P, Burkart F, Bühler F. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 1986;315:533-7
17. Lundberg SM, Franco-Cereda A, Hemsén A, LaCroix JS, Pernow J. Pharmacology of noradrenaline and neuropeptide tyrosine (NPY)-mediated sympathetic co-transmission. Fundam Clin Pharmacol 1990;4:373-91
18. Franco-Cereeda A, Lundberg JM, Dahlöf C. Neuropeptide Y and sympathetic control of the heart contractility and coronary vascular tone. Acta Physiol Scand 1985;124:361-9
19. Ullman B, Jensen-Urstad M, Hulting J, Lundberg JM. Neuropeptide Y, noradrenaline and invasive hemodynamic data in mild to moderate chronic congestive heart failure. Clin Physiol 1993;13:409-18
20. Tyni-Lenné R, Gordon A, Sylvén C. Improved quality of life in chronic heart failure patients following local endurance training with leg muscles. J Cardiac Failure 1996;2:111-17
21. Andersen P, Adams RP, Sjögaard G, Thorboe A, Saltin B. Dynamic knee extension as a model for study of isolated exercising muscle in humans. J Appl Physiol 1985;59: 1647-53
22. Borg GAV. Psychophysical bases of perceived exertion, Med Sci Sports Exc 1982;14:377-81
23. Bergström J. Muscle electrolytes in man. Scand J Clin Lab Invest 1962;68(suppl):14:1-100
24. Chi M, Hintz CS, Coyle EF, Martin III VH, Ivy JL, Nemeth PM, Holloszy JO, Lowry OH. Effects of detraining on enzymes of energy metabolism in individual human muscle fibers. Am J Physiol 1983;244:C2762-87
25. Lowry OH, Passonneau JV. A flexible system of enzymatic analysis. Academic Press, New York, 1972
26. Lin L, Sylvén C, Sotonyi P, Somogyi E, Kaijser L, Jansson E. Myoglobin content and citrate synthase activity in different parts of the normal human heart. J Appl Physiol 1990;69:899-901
27. Essén B, Jansson E, Henriksson J, Taylor AW, Saltin B. Metabolic characteristics of fibre types in human skeletal muscle. Acta Physiol Scand 1975;95:153-65
28. Hjemdahl P. Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection. Methods Enzymol 1987;142:521-34
29. Theodorsson-Norheim E, Hemsén A, Lundberg JM. Radioimmunoassay for neuropeptide Y (NPY): Chromatographic characterization of immuno-reactivity in plasma and tissue extracts. Scand J Clin Lab Invest 1985;124: 129-31
30. Brenner BM, Laragh JH. Biologically active atrial peptides. American Society of Hypertension Symposium Series, vol 1. New York, Raven Press, 1987
31. Bergner M, Bobbitt RA, Carter W, Gilsson B. The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 1981;19:787-806
32. Langius A, Björvell H. Coping ability and functional status in Swedish population sample. Scand J Caring Sci 1993; 7:3-10
33. Henriksson J. Training induced adaptations of skeletal muscle and metabolism during submaximal exercise. J Physiol 1977;270:661-75
34. Andreas S, Vonhof S, Kreuzer H, Fgulla H. Ventilation and dyspnoea during exercise in patients with heart failure. Eur Heart J 1995;16:1886-91
35. Abraham WT, Hensen J, Schrier RW. Elevated plasma noradrenaline concentrations in patients with low output cardiac failure: dependence on increased noradrenaline secretion rates. Clin Sci 1990;79:429-35
36. Francis GS. Hemodynamic and neurohumoral responses to dynamic exercise: normal subjects versus patients with heart disease. Circulation 1987;76 (pt 2): 11-17
37. Ullman B, Lindvall K, Lundberg J, Sigurdsson A, Svedberg K. Response of plasma NPY and noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure. Clin Physiol 1994;14:123-34
38. Pernow J, Lundberg M, Kaijser L, Hjemdahl P, Theodors-son-Norheim E, Martinsson A, Pernow B. Plasma neuropeptide Y-like immunoreactivity and catetholamines dur-ing various degrees of sympathetic activation in man. Clin Physiol 1986;6:561-78
39. Coats A, Adamapoulos S, Meyer TE, Conway J, Sleight P. Effects of physical training in chronic heart failure. Lancet 1990;335:63-6